arsenic has been researched along with Epstein-Barr Virus Infections in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ambinder, RF; Desai, P; Kosowicz, JG; Lee, J; Liu, JO; Stone, J | 1 |
| Block, GJ; Chadwick, RW; Flemington, EK; Lasky, JA; Shan, B; Sides, MD | 1 |
2 other study(ies) available for arsenic and Epstein-Barr Virus Infections
| Article | Year |
|---|---|
Arsenicals, the Integrated Stress Response, and Epstein-Barr Virus Lytic Gene Expression.
Topics: Arsenicals; Biomarkers; Cell Line, Tumor; Cells, Cultured; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Host-Pathogen Interactions; Humans; Models, Biological; Stress, Physiological; Virus Activation; Virus Replication | 2021 |
Epstein - Barr virus Latent Membrane Protein 1 suppresses reporter activity through modulation of promyelocytic leukemia protein-nuclear bodies.
Topics: Arsenic Trioxide; Arsenicals; beta-Galactosidase; Cell Line; Dose-Response Relationship, Drug; Epstein-Barr Virus Infections; Gene Expression Regulation, Leukemic; Gene Expression Regulation, Viral; Gene Silencing; Genes, Reporter; Herpesvirus 4, Human; Humans; Intranuclear Inclusion Bodies; Leukemia, Promyelocytic, Acute; Luciferases; Nuclear Proteins; Oxides; Plasmids; Promyelocytic Leukemia Protein; RNA, Small Interfering; Transcription Factors; Transcription, Genetic; Transfection; Tumor Suppressor Proteins; Viral Matrix Proteins | 2011 |